No Prescription |
 |
 | ||
|
MACLAR Klacid |
|
| ||
No Prescription » Prescription Drugs 10 » MACLAR Klacid Clarithromycin is used to treat certain infections caused by bacteria such as pneumonia (a lung infection) bronchitis (infection of the tubes leading to the lungs) and infections of the ears sinuses skin and throat. It also is used to treat and prevent disseminated Mycobacterium avium complex (MAC) infection [a type of lung infection that often affects people with human immunodeficiency virus (HIV)]. It is used in combination with other medications to eliminate H. pylori a bacteria that causes ulcers. Clarithromycin is in a class of medications called macrolide antibiotics. It works by stopping the growth of bacteria. Antibiotics will not work for colds flu or other viral infections.Clarithromycin comes as a tablet an extended-release (long-acting) tablet and a suspension (liquid) to take by mouth. The regular tablet and liquid are usually taken with or without food every 12 hours (twice a day) for 7-14 days. The long-acting tablet is usually taken with food every 24 hours (once a day) for 7-14 days. Take clarithromycin at around the same time(s) every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take clarithromycin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid well before each use to mix the medication evenly.The tablets should be taken with a full glass of water. Swallow the long-acting tablets whole; do not split chew or crush them.Take clarithromycin until you finish the prescription even if you feel better. If you stop taking clarithromycin too soon your infection may not be completely treated and the bacteria may become resistant to antibiotics.Clarithromycin also is used sometimes to treat other types of infections including Lyme disease (an infection that may develop after a person is bitten by a tick) crypotosporidiosis (an infection that causes diarrhea) cat scratch disease (an infection that may develop after a person is bitten or scratched by a cat) Legionnaires' disease (a type of lung infection) and pertussis (whooping cough; a serious infection that can cause severe coughing). It is also sometimes used to prevent heart infection in patients having dental or other procedures. Talk to your doctor about the possible risks of using this medication for your condition. Buy MACLAR Klacid and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About MACLAR Klacid: Product Type: Prescription Drugs 10 MACLAR ( Klacid Biaxin Generic Clarithromycin ) MACLAR (Klacid Biaxin Generic Clarithromycin) Klacid Biaxin Generic Clarithromycin 250mg Klacid Biaxin Generic Clarithromycin MACLAR
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
